by FDA Listing for Biosimilars: How They Are Evaluated and Approved
29 Dec, 2025The FDA doesn't rate biosimilars like generics-they undergo a rigorous scientific review to prove they're highly similar to reference biologics with no clinically meaningful differences. Learn how approval works, what the Purple Book is, and why only 17 are interchangeable.
READ MORE